Abbott (ABT) Rises Higher Than Market: Key Facts [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
The stock's change was more than the S&P 500's daily gain of 0.38%. Meanwhile, the Dow experienced a rise of 1.47%, and the technology-dominated Nasdaq saw a decrease of 0.23%. Shares of the maker of infant formula, medical devices and drugs have appreciated by 9.07% over the course of the past month, outperforming the Medical sector's gain of 5.96% and lagging the S&P 500's gain of 10.72%. The investment community will be closely monitoring the performance of Abbott in its forthcoming earnings report. In that report, analysts expect Abbott to post earnings of $1.19 per share. This would mark year-over-year growth of 15.53%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $10.14 billion, up 0.49% from the year-ago period. For the annual period, the Zacks Consensus Estimates anticipate earnings of $4.44 per share and a revenue of $40.01 billion, signifying shifts of -16.85% and -8.35%, respectively, from the last year. It is also important to note
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott must pay US$495-million in premature infant formula trial, jury finds [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Abbott Labs falls after jury awards plaintiff $95M in damages in baby formula case [Seeking Alpha]Seeking Alpha
- Abbott must pay $95 million in premature infant formula trial, jury finds [CNBC]CNBC
- Cardiac Prosthetic Devices Market size is set to grow by USD 5.07 billion from 2024-2028, Rising prevalence of cardiac disorders to boost the market growth, Technavio [Yahoo! Finance]Yahoo! Finance
- An ugly earnings report from a competitor is good news for Abbott Labs [CNBC]CNBC
ABT
Earnings
- 7/18/24 - Beat
ABT
Sec Filings
- 7/18/24 - Form 8-K
- 7/2/24 - Form 4
- 7/2/24 - Form 4
- ABT's page on the SEC website